Elemental Formula denied as non-formulary by Humana?

Humana's specific coverage criteria for elemental formula are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Elemental Formula as Non-Formulary — and Your Appeal Options

A non-formulary denial means the specific elemental formula product your prescriber ordered is not included on Humana's covered product list for your plan. Humana may offer a different formula product on its formulary that it considers equivalent, or no formula product at all under the relevant benefit category. Non-formulary denials are not automatic dead ends — formulary exception processes and appeals exist specifically for situations where no formulary alternative is clinically appropriate.

## Why This Denial Is Appealable

Formulary exception rights are protected under federal regulations for most plan types. If your prescriber documents that the formulary alternative(s) Humana offers are clinically inappropriate for your condition — because of your diagnosis, prior failure on those alternatives, intolerance, or specific clinical requirements — you are entitled to request a formulary exception. When an exception is denied, the full internal and external appeal process applies. Elemental formulas are medically distinct products; a patient whose condition requires elemental composition may have a strong clinical basis for exception if semi-elemental or standard formula alternatives are on the formulary.

## Your Federal Appeal Rights

• Formulary exception: File a formulary exception request, supported by your prescriber's letter, as a first step. Humana must have a formal exception process.
• Internal appeal: If the exception is denied, you have the right to a full internal appeal under ERISA §503 (employer plans) or applicable state law, typically within 180 days of the denial.
• External review: Under ACA §2719, a final internal denial on a formulary exception can proceed to independent external review, generally within four months of the final internal decision.
• Expedited review: If clinical urgency applies, expedited review — typically within 72 hours — is available.

## What to Gather Before You File

1. Denial letter — the specific reason for the non-formulary determination and any formulary alternative(s) Humana cited. 2. Humana's formulary and exception policy — request both. Know what is covered and what the exception criteria are. 3. Prescriber's formulary exception / medical-necessity letter — must address each formulary alternative Humana identified and explain why each is clinically inappropriate for your patient: prior failure with dates/outcomes, intolerance, or clinical contraindication based on your diagnosis. 4. Diagnosis and clinical documentation — chart records confirming the condition requiring elemental nutritional support and the clinical reasoning behind the product selection. 5. Prior-treatment records — dates and outcomes of any prior nutritional interventions, including any formulary products previously tried. 6. Relevant guideline organization reference — cite the applicable clinical society or guideline organization supporting the prescribed product for your condition.

## Criteria-Mapping Structure

| Non-Formulary Exception Criterion | Your Supporting Evidence | |---|---| | Formulary alternative(s) are clinically inappropriate | [Prescriber letter, trial-failure records, or contraindication basis] | | Prescribed product is medically necessary for this patient | [Diagnosis records + prescriber letter] | | Prior formulary products tried or contraindicated | [Treatment history with dates/outcomes] | | Guideline support for the prescribed product in this indication | [Prescriber letter citing guideline organization] |

A formulary exception request paired with a complete appeal package is often the fastest path to coverage for non-formulary elemental formula. Document clinical differentiation clearly, and your case will be positioned for success at both the internal and external review levels.